BCG vaccination and tuberculosis prevention: A forty years cohort study, Monastir, Tunisia

PloS One
Cyrine BennasrallahAsma Sriha Belguith

Abstract

We aimed to describe incidence, trends of tuberculosis (TB) over 18 years and to evaluate the impact of the BCG vaccine after four decades of immunization program according to three protocols. We performed a cohort study including declared cases in Monastir from January 1, 2000 to December 31, 2017. We reported 997 cases of TB. The predominant site was pulmonarylocalization (n = 486). The age standardized incidence of pulmonary and lymph node TB per 100,000 inh were 5.71 and 2.57 respectively. Trends were negative for pulmonary TB (PTB) (b = - 0.82; r = -0.67; p<10-3) and positive for lymph node localization (b = 1.31; r = 0.63; p<10-3). We had not notified cases of HIV associated with TB. Crude incidence rate (CIR) of PTB per 100,000 inh was 8.17 in Non-Vaccinated Cohort (NVC) and 2.85 in Vaccinated Cohort (VC) (p < 0.0001). Relative risk reduction (RRR) of BCG vaccination was 65.1% (95%CI:57.5;71.4) for pulmonary localization and 65% (95%CI:55; 73) for other localizations. We have not established a significant RRR of BCG vaccination on lymph node TB. Protocol 3 (at birth) had the highest effectiveness with a RRR of 96.7% (95%CI: 86.6%; 99.2%) and 86% (95%CI:71%;91%) in patients with PTB and other localizations TB respectively...Continue Reading

References

Mar 1, 1980·The Journal of Hospital Infection·C J NobleJ R Pattison
Jun 11, 1994·Lancet·E DruckerB Sckell
Jun 16, 2004·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·N MeddebS Sellami
Feb 28, 2007·Archives of Internal Medicine·Michael N BatesKirk R Smith
Sep 7, 2007·The European Respiratory Journal·M ForssbohmH L Rieder
Jun 23, 2009·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Tim FaderNasir Ahmad Nasir
Feb 12, 2010·Revue des maladies respiratoires·G Jebrak, UNKNOWN Initiatives BPCO
Mar 24, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paul FineDavid L Heymann
Jul 10, 2012·BMC Public Health·Gemeda AbebeRobert Colebunders
Apr 1, 2009·Journal of Bronchology & Interventional Pulmonology·Rosa Cordovilla, Ana Jiménez-Massa
Mar 12, 2013·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Gisele Pinto de OliveiraDraurio Barreira
Dec 18, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Punam MangtaniJonathan A Sterne
Feb 24, 2015·Immunological Reviews·Stéphanie Boisson-DupuisLaurent Abel
Sep 18, 2015·Lancet·Keertan DhedaGary Maartens
Oct 21, 2015·Nature Immunology·Dale I GodfreyD Branch Moody
Sep 22, 2016·International Journal of Mycobacteriology·Salma SmaouiFérièle Messadi-Akrout
Nov 25, 2017·International Journal of Mycobacteriology·Zied A Gaifer
Jul 12, 2018·The New England Journal of Medicine·Elisa NemesUNKNOWN C-040-404 Study Team

❮ Previous
Next ❯

Citations

Nov 23, 2021·The Libyan Journal of Medicine·Sarra MelkiAhmed Ben Abdelaziz

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques

Software Mentioned

Monastir
Excel
SPSS Statistics

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.